mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.005 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.005 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
Nutlin-3a (-) |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.006 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.006 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.006 |
mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.006 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.006 |
mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |